NSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.
Gland Pharma Ltd: key numbers
- Share price
- ₹3,095.10
- Market cap
- ₹51,073 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 45.2×Sector 48.7×
- Promoter holding
- 45.75%-6.02% QoQ
- FII holding
- 10.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gland Pharma Ltd
All →Gland Pharma Business Update
Gland Pharma reports that USFDA concluded an unannounced cGMP inspection at its Dundigal formulation facility with four procedural Form 483 observations. No monetary impact is stated, and corrective actions will be submitted within the stipulated period.
Gland Pharma Board Meeting Date
Gland Pharma Ltd scheduled a board meeting for November 06, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026.
Gland Pharma Other Announcement
Gland Pharma Limited has filed the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Gland Pharma Annual General Meeting
Gland Pharma issued a postal ballot notice to seek shareholder approval for appointing Mr. Xingli Wang as Non-Executive Director. E-voting runs October 7 to November 5, 2026.
Gland Pharma Management Change
Gland Pharma Limited announced the resignation of director Wenjie Zhang and the appointment of Xingli Wang as a Non-Executive Non-Independent Director effective October 1, 2026.
Gland Pharma Acquisition Worth ₹199.5 Cr
Gland Pharma Limited's board approved a USD 21 million investment in its subsidiary, Gland USA, to acquire a 60% stake in Novelstar Pharma Inc. This acquisition facilitates business expansion in the USA.
- Value
- ₹199.5 Cr
- Execution
- By October 31, 2026
Other management change announcements
All →Vishal Mega Mart Management Change
Vishal Mega Mart appointed Ms. Ashok Revathy as Non-Executive Independent Director for a five-year first term from October 30, 2026. The board change follows NRC recommendation and carries no financial amount.
- Execution
- 5 years (first term as Independent Director, effective October 30, 2026)
Dish TV India Management Change
Dish TV India reports that Chief Customer Experience Officer Swami Mehra has resigned, effective close of business on 30 October 2026. He will also cease to be part of senior management from that date.
Kamdhenu Ventures Management Change
Kamdhenu Ventures appointed Saroj Punhani as Non-Executive Independent Director for a 60-month term, effective 30 October 2026. The appointment was approved at the board meeting held the same day.
Ujjivan Small Finance Bank Management Change
Ujjivan SFB's Head of Internal Audit, Vijayalakshmi Muddu, voluntarily retired effective 30 October 2026. The senior management personnel change is disclosed under SEBI rules.
Aadi Industries Management Change
Aadi Industries appointed Siddharth Mahicha as CFO effective 30 October 2026. Whole-Time Director and CFO Tejas Sampat resigned from both roles effective the same day.
Ganesh Housing Management Change
Ganesh Housing approved unaudited half-year results to September 2026. It also appointed R N Pathak & Co. as internal auditor for FY2026-27.